Ehret Totta, Torelli Francesca, Klotz Christian, Pedersen Amy B, Seeber Frank
FG16 - Mycotic and Parasitic Agents and Mycobacteria, Robert Koch InstituteBerlin, Germany.
Department of Molecular Parasitology, Humboldt-Universität zu BerlinBerlin, Germany.
Front Cell Infect Microbiol. 2017 Jun 7;7:238. doi: 10.3389/fcimb.2017.00238. eCollection 2017.
Rodents, in particular , have a long and invaluable history as models for human diseases in biomedical research, although their translational value has been challenged in a number of cases. We provide some examples in which rodents have been suboptimal as models for human biology and discuss confounders which influence experiments and may explain some of the misleading results. Infections of rodents with protozoan parasites are no exception in requiring close consideration upon model choice. We focus on the significant differences between inbred, outbred and wild animals, and the importance of factors such as microbiota, which are gaining attention as crucial variables in infection experiments. Frequently, mouse or rat models are chosen for convenience, e.g., availability in the institution rather than on an unbiased evaluation of whether they provide the answer to a given question. Apart from a general discussion on translational success or failure, we provide examples where infections with single-celled parasites in a chosen lab rodent gave contradictory or misleading results, and when possible discuss the reason for this. We present emerging alternatives to traditional rodent models, such as humanized mice and organoid primary cell cultures. So-called recombinant inbred strains such as the Collaborative Cross collection are also a potential solution for certain challenges. In addition, we emphasize the advantages of using wild rodents for certain immunological, ecological, and/or behavioral questions. The experimental challenges (e.g., availability of species-specific reagents) that come with the use of such non-model systems are also discussed. Our intention is to foster critical judgment of both traditional and newly available translational rodent models for research on parasitic protozoa that can complement the existing mouse and rat models.
尤其是啮齿动物,在生物医学研究中作为人类疾病模型有着悠久且不可替代的历史,尽管在一些情况下它们的转化价值受到了挑战。我们提供了一些例子,说明啮齿动物作为人类生物学模型并不理想,并讨论了影响实验的混杂因素,这些因素可能解释了一些误导性结果。用原生动物寄生虫感染啮齿动物在模型选择时也需要仔细考虑,这并不例外。我们重点关注近交系、远交系和野生动物之间的显著差异,以及微生物群等因素的重要性,这些因素作为感染实验中的关键变量正日益受到关注。通常,选择小鼠或大鼠模型是出于方便,例如,机构中是否有现成的,而不是基于对它们是否能回答特定问题的无偏见评估。除了对转化成功或失败的一般性讨论外,我们还提供了一些例子,说明在选定的实验小鼠中感染单细胞寄生虫会产生矛盾或误导性结果,并尽可能讨论其原因。我们介绍了传统啮齿动物模型的新兴替代方案,如人源化小鼠和类器官原代细胞培养。所谓的重组近交系,如协作杂交品系集合,也是应对某些挑战的潜在解决方案。此外,我们强调了使用野生啮齿动物研究某些免疫学、生态学和/或行为学问题的优势。还讨论了使用此类非模型系统所带来的实验挑战(例如,物种特异性试剂的可用性)。我们的目的是促进对传统和新出现的用于寄生原生动物研究的转化啮齿动物模型进行批判性判断,这些模型可以补充现有的小鼠和大鼠模型。